ARCT

Arcturus Therapeutics Holdings (ARCT)

About Arcturus Therapeutics Holdings (ARCT)

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Details

Daily high

$25.29

Daily low

$23.51

Price at open

$24.91

52 Week High

$45.00

52 Week Low

$17.52

Market cap

645.8M

Dividend yield

0.00%

Volume

215,611

Avg. volume

401,273

P/E ratio

-9.30

Arcturus Therapeutics Holdings News